The following is a summary of available-for-sale marketable securities, excluding those securities classified within cash and cash equivalents, on the condensed consolidated balance sheets as of September 30, 2026. The Company had no available-for-sale marketable securities as of December 31, 2025.


	September 30, 2026
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable securities:
U.S. Treasury securities	$	99,280	$	—	$	(42)	$	99,238

Commercial paper	79,440		—		(33)		79,407
Total Marketable securities	$	178,720	$	—	$	(75)	$	178,645

Interest income from investments was $5,083, and $2,630 for the three months ended September 30, 2026 and 2025, respectively, and $14,350 and $9,489 for the nine months ended September 30, 2026 and 2025, respectively. As of September 30, 2026, all of the Company’s available-for-sale short-term investments were due within one year.

As of September 30, 2026, the Company held nine securities that were in an unrealized loss position. The Company does not intend to sell and expects that it is more likely than not that it will not be required to sell these securities until such time as the value recovers or the securities mature. Unrealized losses from fixed-income securities are primarily attributable to changes in interest rates and not credit-related factors based on the Company’s evaluation of available evidence. To determine whether a decline in value is related to credit loss, the Company evaluates, among other factors: the extent to which the fair value is less than the amortized cost basis, changes to the rating of the security by a rating agency and any adverse conditions specifically related to an issuer of a security or its industry. Management does not believe any remaining unrealized losses represent impairments based on our evaluation of available evidence. Unrealized gains and losses on marketable securities are presented net of tax.